NI–01
| Distinct and nonredundant role of myeloid subsets in mouse models of
Alzheimer`s disease
K. Katrin, A. Mildner (Freiburg i.Brs.), B. Schlevogt (Göttingen),
C. Böttcher (Berlin), D. Erny (Freiburg i.Brs.), M. Kummer (Bonn),
U. Wolke (Freiburg i.Brs.), M.Q. Quinn (Berlin), W. Brück (Göttingen),
M. Heneka (Bonn), J. Priller (Berlin), M. Prinz (Freiburg i.Brs.) |
NI–03
| Reduced demyelination, inflammation, axonal damage and
oligodendroglial pathology after preventive Laquinimod treatment in
the murine cuprizone model
C. Wegner, R. Pförtner, W. Brück (Göttingen) |
NI–04 | Experimental antiphospholipid syndrome causes alterations in
neurotransmitter receptor binding densities which may reflect the
molecular basis of neurological impairment
K. Frauenknecht (Mainz), A. Katzav (Tel Aviv/IL), H. Bauer,
C. Grimm (Mainz), J. Chapman (Tel Aviv/IL), C. Sommer (Mainz) |
